A diclofenac suppository―nabumetone combination therapy for arthritic pain relief and a monitoring method for the diclofenac binding capacity of HSA site II in rheumatoid arthritisSETOGUCHI, Nao; TAKAMURA, Norito; FUJITA, Ken-Ichi et al.Biopharmaceutics & drug disposition. 2013, Vol 34, Num 2, pp 125-136, issn 0142-2782, 12 p.Article

Metabolism of 7-ethoxycoumarin, safrole, flavanone and hydroxyflavanone by cytochrome P450 2A6 variantsUNO, Tomohide; OBE, Yuichiro; OGURA, Chika et al.Biopharmaceutics & drug disposition. 2013, Vol 34, Num 2, pp 87-97, issn 0142-2782, 11 p.Article

Time-dependent inhibition of CYP3A4 by sertraline, a selective serotonin reuptake inhibitorMASUBUCHI, Yasuhiro; KAWAGUCHI, Yuki.Biopharmaceutics & drug disposition. 2013, Vol 34, Num 8, pp 423-430, issn 0142-2782, 8 p.Article

Population-based meta-analysis of hydrochlorothiazide pharmacokineticsVAN WART, Scott A; SHOAF, Susan E; MALLIKAARJUN, Suresh et al.Biopharmaceutics & drug disposition. 2013, Vol 34, Num 9, pp 527-539, issn 0142-2782, 13 p.Article

Drug disposition in three dimensions : An update on stereoselectivity in pharmacokineticsBROCKS, Dion R.Biopharmaceutics & drug disposition. 2006, Vol 27, Num 8, pp 387-406, issn 0142-2782, 20 p.Article

Pharmacokinetic interaction of nelfinavir and methadone in intravenous drug usersHSYU, Poe-Hirr; LILLIBRIDGE, Jim; DANIELS, Elaine et al.Biopharmaceutics & drug disposition. 2006, Vol 27, Num 2, pp 61-68, issn 0142-2782, 8 p.Article

The effect of tamoxifen on the pharmacokinetics of letrozole in female ratsTAO, X; BRODIE, A. M. H; NNANE, I. P et al.Biopharmaceutics & drug disposition. 2006, Vol 27, Num 7, pp 335-344, issn 0142-2782, 10 p.Article

Everolimus drug interactions : Application of a classification system for clinical decision makingKOVARIK, John M; BEYER, Doris; SCHMOUDER, Robert L et al.Biopharmaceutics & drug disposition. 2006, Vol 27, Num 9, pp 421-426, issn 0142-2782, 6 p.Article

Fate of tritiated didemnin B in mice : Excretion and tissue concentrations after an intraperitoneal doseBEASLEY, Val R; BRUNO, Sally J; BURNER, John S et al.Biopharmaceutics & drug disposition. 2005, Vol 26, Num 8, pp 341-351, issn 0142-2782, 11 p.Article

Interspecies pharmacokinetic scaling of DA-8159, a new erectogenic, in mice, rats, rabbits and dogs, and prediction of human pharmacokineticsSHIM, Hyun J; KIM, Yu C; LEE, Joo H et al.Biopharmaceutics & drug disposition. 2005, Vol 26, Num 7, pp 269-277, issn 0142-2782, 9 p.Article

Pharmacokinetics of amiodarone in hyperlipidemic and simulated high fat-meal rat modelsSHAYEGANPOUR, Anooshirvan; JUN, Andrew S; BROCKS, Dion R et al.Biopharmaceutics & drug disposition. 2005, Vol 26, Num 6, pp 249-257, issn 0142-2782, 9 p.Article

Preclinical pharmacokinetics of a novel HIV-1 attachment inhibitor BMS-378806 and prediction of its human pharmacokineticsZHENG YANG; ZADJURA, Lisa; MEANWELL, Nicholas et al.Biopharmaceutics & drug disposition. 2005, Vol 26, Num 9, pp 387-402, issn 0142-2782, 16 p.Article

Bioavailability of Divalproex extended-release formulation relative to the Divalproex delayed-release formulationDUTTA, Sandeep; YIMING ZHANG.Biopharmaceutics & drug disposition. 2004, Vol 25, Num 8, pp 345-352, issn 0142-2782, 8 p.Article

Comparative evaluation of Digoxin concentrations determined by three assay systems: TDx, IMx and OPUSKAGAWA, Yoshiyuki; IWAMOTO, Takuya; MATSUDA, Hiroaki et al.Biopharmaceutics & drug disposition. 2004, Vol 25, Num 1, pp 21-26, issn 0142-2782, 6 p.Article

Comparative pharmacokinetics of acetyl salicylic acid and its metabolites in children suffering from autoimmune diseasesJUAREZ OLGUIN, Hugo; FLORES PEREZ, Janett; LARES ASSEFF, Ismael et al.Biopharmaceutics & drug disposition. 2004, Vol 25, Num 1, pp 1-7, issn 0142-2782, 7 p.Article

Disposition of WR-1065 in the liver of tumor-bearing rats following regional vs systemic administration of amifostineLEVI, Micha; DEREMER, Susan J; CHUNZHI DOU et al.Biopharmaceutics & drug disposition. 2004, Vol 25, Num 1, pp 27-35, issn 0142-2782, 9 p.Article

Effects of β-estradiol and propofol on the 4-methylumbelliferone glucuronidation in recombinant human UGT isozymes 1A1, 1A8 and 1A9MANO, Yuji; USUI, Takashi; KAMIMURA, Hidetaka et al.Biopharmaceutics & drug disposition. 2004, Vol 25, Num 8, pp 339-344, issn 0142-2782, 6 p.Article

Interaction of dexloxiglumide, a cholecystokinin type-1 receptor antagonist, with human cytochromes P450HALL, Michael; PERSIANI, Stefano; CHEUNG, Yen-Ling et al.Biopharmaceutics & drug disposition. 2004, Vol 25, Num 4, pp 163-176, issn 0142-2782, 14 p.Article

Comparative pharmacokinetics and pharmacodynamics of propranolol and atenolol in normolipaemic and hyperlipidaemic obese subjectsWOJCICKI, Jerzy; JAROSZYNSKA, Maria; DROZDZIK, Marek et al.Biopharmaceutics & drug disposition. 2003, Vol 24, Num 5, pp 211-218, issn 0142-2782, 8 p.Article

Evaluation of the pharmacokinetic profiles of the new testosterone topical gel formulation, Testim, compared to androgelMARBURY, T; HAMILL, E; BACHAND, R et al.Biopharmaceutics & drug disposition. 2003, Vol 24, Num 3, pp 115-120, issn 0142-2782, 6 p.Article

Impact of Solutol HS 15 on the pharmacokinetic behaviour of colchicine upon intravenous administration to male Wistar ratsBITTNER, Beate; BRAVO GONZALEZ, Roberto Carlos; WALTER, Isabelle et al.Biopharmaceutics & drug disposition. 2003, Vol 24, Num 4, pp 173-181, issn 0142-2782, 9 p.Article

Plasma concentration profiles of ketamine and norketamine after administration of various ketamine preparations to healthy Japanese volunteersYANAGIHARA, Yoshitsugu; OHTANI, Michiteru; KARIYA, Satoru et al.Biopharmaceutics & drug disposition. 2003, Vol 24, Num 1, pp 37-43, issn 0142-2782, 7 p.Article

Acetyl-L-carnitine permeability across the blood-brain barrier and involvement of carnitine transporter OCTN2INANO, Akihiro; SAI, Yoshimichi; NIKAIDO, Hiroko et al.Biopharmaceutics & drug disposition. 2003, Vol 24, Num 8, pp 357-365, issn 0142-2782, 9 p.Article

Mometasone furoate degradation and metabolism in human biological fluids and tissuesXIAO WEI TENG; CUTLER, David J; DAVIES, Neal M et al.Biopharmaceutics & drug disposition. 2003, Vol 24, Num 8, pp 321-333, issn 0142-2782, 13 p.Article

Pharmacokinetic characterization of a human immunodeficiency virus protease inhibitor, saquinavir, during ethanol intake in ratsSHIBATA, Nobuhito; KAGEYAMA, Michiharu; KISHIDA, Tomoyuki et al.Biopharmaceutics & drug disposition. 2003, Vol 24, Num 8, pp 335-344, issn 0142-2782, 10 p.Article